OBJECTIVE: To examine the impact of the Medicare drug benefit (Part D) on the distribution of out-of-pocket pharmacy spending among older adults. METHODS: We used a pre-post-with-comparison-group design to compare four groups of beneficiaries continuously enrolled in a Medicare Advantage plan between 2004 and 2007: three intervention groups with no or limited (quarterly caps of $150 or $350) prior coverage that obtained Part D benefits in 2006 and a comparison group with stable drug coverage from 2004 to 2007. RESULTS: The comparison group's out-of-pocket drug spending was stable throughout 2004-2007, whereas Part D reduced out-of-pocket spending 13.4% among those without prior coverage (95% confidence interval [CI] -17.1% to -9.1%) and 15.9% among those with $150 quarterly caps (95% CI -19.1% to -12.8%) relative to the comparison group. Individuals in the top decile of drug spending paid a greater share of their costs out-of-pocket than others in the top 5 deciles. DISCUSSION: Although Part D reduced out-of-pocket expenditures for older adults, those with the highest drug spending still pay a substantial share of their drug costs out-of-pocket. Thus, the Part D benefit does not achieve a primary purpose of insurance-to offer the greatest financial protection to those at the highest risk.
OBJECTIVE: To examine the impact of the Medicare drug benefit (Part D) on the distribution of out-of-pocket pharmacy spending among older adults. METHODS: We used a pre-post-with-comparison-group design to compare four groups of beneficiaries continuously enrolled in a Medicare Advantage plan between 2004 and 2007: three intervention groups with no or limited (quarterly caps of $150 or $350) prior coverage that obtained Part D benefits in 2006 and a comparison group with stable drug coverage from 2004 to 2007. RESULTS: The comparison group's out-of-pocket drug spending was stable throughout 2004-2007, whereas Part D reduced out-of-pocket spending 13.4% among those without prior coverage (95% confidence interval [CI] -17.1% to -9.1%) and 15.9% among those with $150 quarterly caps (95% CI -19.1% to -12.8%) relative to the comparison group. Individuals in the top decile of drug spending paid a greater share of their costs out-of-pocket than others in the top 5 deciles. DISCUSSION: Although Part D reduced out-of-pocket expenditures for older adults, those with the highest drug spending still pay a substantial share of their drug costs out-of-pocket. Thus, the Part D benefit does not achieve a primary purpose of insurance-to offer the greatest financial protection to those at the highest risk.
Authors: Yuting Zhang; Julie M Donohue; Judith R Lave; Gerald O'Donnell; Joseph P Newhouse Journal: N Engl J Med Date: 2009-07-02 Impact factor: 91.245
Authors: Wesley Yin; Anirban Basu; James X Zhang; Atonu Rabbani; David O Meltzer; G Caleb Alexander Journal: Ann Intern Med Date: 2008-01-07 Impact factor: 25.391
Authors: Walid F Gellad; Haiden A Huskamp; Angela Li; Yuting Zhang; Dana Gelb Safran; Julie M Donohue Journal: J Gen Intern Med Date: 2011-07-13 Impact factor: 5.128
Authors: Julie M Donohue; Yuting Zhang; Men Aiju; Subashan Perera; Judith R Lave; Joseph T Hanlon; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2011-12 Impact factor: 4.105
Authors: Jennifer M Polinski; M Alan Brookhart; Robert J Glynn; Sebastian Schneeweiss Journal: J Clin Psychopharmacol Date: 2012-02 Impact factor: 3.153
Authors: Bruce Y Lee; Kristina M Bacon; Julie M Donohue; Ann E Wiringa; Rachel R Bailey; Richard K Zimmerman Journal: Vaccine Date: 2011-01-06 Impact factor: 3.641
Authors: Joseph T Hanlon; Robert M Boudreau; Subashan Perera; Elsa S Strotmeyer; Anne B Newman; Eleanor M Simonsick; Ronald I Shorr; Douglas C Bauer; Julie M Donohue Journal: Am Heart J Date: 2013-08-28 Impact factor: 4.749